Tubular carcinoma, treatable and slow-growing, has a good prognosis and often needs less aggressive treatment.

Mechanosensing is like a touchscreen on a smartphone. When you press on the screen, sensors detect the pressure and trigger a ...

The blood-CSF barrier has been far less studied than the blood-brain barrier. Scientists have detected age-related changes in gene expression in the choroid plexus, and have linked these to increased ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for seriou ...

Breast cancer remains the most frequently diagnosed malignancy in women in the United States, with nearly 317,000 new cases expected in 2025.  In addi | Cancer ...

According to their model, if they changed the magnitude of various parameters, they should be able to rescale the curves so that they essentially collapse onto a single curve. “This makes our ...

Porosome Therapeutics, Inc. announced the Orphan Drug Designation of its cystic fibrosis therapy by the Food and Drug Administration (FDA).

Commissions do not affect our editors' opinions or evaluations. A business line of credit is a handy way to access financing as needed rather than receiving a lump-sum payment such as with a small ...

Those results were also replicated in epithelial cells which line the surface or organs in various parts of the body. This suggests that AP2A1 might be a universal part of the ageing process, no ...

Researchers from Osaka University, Japan claim to have found a cellular 'master switch' which can reverse the process of ...

A newly published study in Genes & Diseases highlights the crucial role of the mammalian target of rapamycin (mTOR) pathway in the progression of ...

In a nutshell Researchers discovered that a protein called AP2A1 acts as a master switch controlling whether cells behave young or old When scientists reduced AP2A1 levels in aged cells, they showed ...